Form 4: AdaptHealth CTO Acquires 63,449 Restricted Stock Units

AdaptHealth Corp.'s Chief Technology Officer, Albert A. Prast, acquired 63,449 restricted stock units of common stock.

Summary

• Albert A. Prast, Chief Technology Officer of AdaptHealth Corp. (AHCO), acquired 63,449 shares of common stock.
• The transaction occurred on January 30, 2026.
• These shares represent restricted stock units (RSUs) and will be settled in common stock upon vesting.
• The acquisition price for these units was $0, which is typical for RSU grants.
• Following this transaction, Mr. Prast directly beneficially owns 442,907 shares of AdaptHealth Corp. common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, indicating continued executive alignment and retention through standard equity compensation practices, which is generally favorable for corporate governance.

Positives

• The grant of restricted stock units to a key executive like the Chief Technology Officer aligns management incentives with long-term shareholder interests.
• Increased beneficial ownership by a senior officer demonstrates continued commitment and confidence in the company's future.

Industry Context

StockSavvy.ai notes that RSU grants are a common form of executive compensation in the healthcare services industry, particularly for technology officers, to incentivize long-term performance and retention. This practice is widely adopted to align the interests of key management with those of shareholders.

Comparison to Industry Standards

• RSU grants are a standard component of executive compensation packages across various industries, including healthcare. Companies like CVS Health (CVS) and UnitedHealth Group (UNH) frequently utilize similar equity-based incentives for their senior leadership to align their interests with long-term shareholder value creation.
• The grant of 63,449 units to a Chief Technology Officer is within typical ranges for a company of AdaptHealth's size and market position, reflecting a commitment to retaining key talent and fostering long-term performance.

Stakeholder Impact

• Shareholders: Potential positive impact through improved executive alignment and retention, which can contribute to long-term value creation.
• Employees: No direct impact mentioned in this filing.

Next Steps

• The restricted stock units will vest over time, leading to their settlement in common stock according to the terms of the grant.

Key Dates

Recommendation

This Form 4 reports a routine grant of restricted stock units to a key executive. While it signals continued executive alignment, it does not present new information that would fundamentally alter the investment thesis for AdaptHealth Corp. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

AdaptHealth, AHCO, Form 4, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Albert Prast, Chief Technology Officer